$21MSeries A, 27 May 2026
Series A led by Transformation Capital, bringing total funding to about $25M, to accelerate pharma commercialization work.
- Amount
- $21M
- Stage
- Series A
- Announced
- 27 May 2026
- Lead
- Transformation Capital
- Other investors
- Twelve Below, Virtue Ventures
- Use of funds
- Series A led by Transformation Capital, bringing total funding to about $25M, to accelerate pharma commercialization work.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Solstice raises $21M Series A for pharma commercialization hitconsultant.net
Solstice raises $21M Series A for pharma commercialization ventureburn.com